emids Acquires Quovantis Technologies in Latest Expansion of Human-Centered, Design-Led Product Development and Software Engineering Capabilities

Deal signals the next chapter in the company’s focus on driving digital customer experience and innovation in the payer, provider and life sciences sectors

New Delhi: emids, a leader in digital engineering and transformation solutions to the healthcare and life sciences industry, today announced the acquisition of Delhi-based Quovantis Technologies, an award-winning user experience design and software development company that enables health technology and product companies to deliver compelling digital experiences for web, mobile and wearables. The terms of the deal were not disclosed.

emids, which has built its reputation as one of healthcare’s most trusted partners for health information technology(HIT) engineering and development, is going strategically upstream with this latest deal on the heels of its acquisition earlier this year of design-led engineering firm Macadamian.

The combined expertise puts emids in a unique position, offering its clients industry-leading data science, engineering and business strategy acumen plus the ability to take an innovative idea from concept to MVP to full-scale enterprise solution and with speed to market.

“We take a human-centeredand iterative approach to innovation,” said Quovantis Founder and CEO Tarun Kohli. “Our customers don’t have to wait months to launch their products to understand a product-market fit. We help them launch products incrementally, see what we did right or wrong, and then calibrate that.”

Kumar Kolin, emids Chief Technology Officer, said “The addition of Quovantis now gives us permission to say, let us sit down with you to think about the problem you’re trying to solve for, let’s help you build, test and iterate that solution, and let’s see it all the way through with you and help figure out how to scale it for the enterprise. This puts emids on the map as a top-tier product development partner, capable of the design, build and large-scale commercialization of novel digital ideas and technologies.”

emids sees this as an increasingly important capability in the midst and wake of COVID-19, where emids’ deep healthcare domain expertise puts its partners at a distinct competitive advantage in bringing mobile, web, cloud and emerging technology solutions to market faster.

Kohli describes Quovantis as, “The company that gets married to the users’ problems and creates delightful solutions using the combination of design, strong engineering culture, and iterative development approach.I like to think of design-led engineering as the connective tissue that brings emids customers the benefit of nimbleness combined with a deep understanding of design-led engineering in the entire healthcare stack.”